![Genevieve Hansen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Genevieve Hansen
Presidente presso Vet Therapeutics, Inc.
Profilo
Genevieve Hansen is currently the Director at Vetica Labs, Inc. and the President & Chief Scientific Officer at Vet Therapeutics, Inc. She previously worked as the Director-Protein Therapeutics at Diversa Corp.
and as the Vice President-Research at Lpath, Inc. Hansen received her graduate and doctorate degrees from Université Paris 1 Panthéon-Sorbonne.
Posizioni attive di Genevieve Hansen
Società | Posizione | Inizio |
---|---|---|
Vet Therapeutics, Inc.
![]() Vet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Elanco Animal Health, Inc., Vet Therapeutics, Inc. develops antibodies and pharmaceutical products for animals. The company is based in Del Mar, CA. Vet Therapeutics was acquired by Aratana Therapeutics, Inc., part of Elanco Animal Health, Inc. from July 19, 2019 on October 16, 2013 for $55.29 million. | Presidente | - |
Vetica Labs, Inc.
![]() Vetica Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Vetica Labs, Inc. engages in other industry group. The company is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Genevieve Hansen
Società | Posizione | Fine |
---|---|---|
Diversa Corp.
![]() Diversa Corp. Miscellaneous Commercial ServicesCommercial Services Diversa searches high and low for DNA. In its quest to develop new enzymes and other active biological compounds, the biotechnology company collects and catalogs the DNA of organisms in diverse environments (from manure piles to tropical islands). A variety of manufacturers license these compounds from the firm to develop or improve their products, which include detergents, oils, animal feeds, and pharmaceuticals. Diversa's products include enzymes for the oil and gas industry | Corporate Officer/Principal | - |
Lpath, Inc.
![]() Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Genevieve Hansen
Université Paris 1 Panthéon-Sorbonne | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
Diversa Corp.
![]() Diversa Corp. Miscellaneous Commercial ServicesCommercial Services Diversa searches high and low for DNA. In its quest to develop new enzymes and other active biological compounds, the biotechnology company collects and catalogs the DNA of organisms in diverse environments (from manure piles to tropical islands). A variety of manufacturers license these compounds from the firm to develop or improve their products, which include detergents, oils, animal feeds, and pharmaceuticals. Diversa's products include enzymes for the oil and gas industry | Commercial Services |
Vetica Labs, Inc.
![]() Vetica Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Vetica Labs, Inc. engages in other industry group. The company is headquartered in San Diego, CA. | Commercial Services |
Lpath, Inc.
![]() Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Health Technology |
Vet Therapeutics, Inc.
![]() Vet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Elanco Animal Health, Inc., Vet Therapeutics, Inc. develops antibodies and pharmaceutical products for animals. The company is based in Del Mar, CA. Vet Therapeutics was acquired by Aratana Therapeutics, Inc., part of Elanco Animal Health, Inc. from July 19, 2019 on October 16, 2013 for $55.29 million. | Health Technology |
- Borsa valori
- Insiders
- Genevieve Hansen